The progression of PCa is a complex process involving numerous molecular pathways, of which the phosphatidylinositol 3-kinase–AKT–mammalian target of rapamycin (PI3K–AKT–mTOR) signaling pathway is the key regulatory pathway16,17. This evidence concerns the gene AKT1 and posterior cortical atrophy.